LD-2 disclosure · 2nd Quarter - Report
MEMSEL, INC.
Client
- Name
- MEMSEL, INC.
- Description
- Scientific research & development company
- Location
- Texas · United States of America
Registrant
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act,FY2024 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026
LobbyistsJENNIFER CAVE · mr MICHAEL ANTHONY SHUPP · MADHUMITHA THYAGARAJAN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Defense
Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act,FY2024 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026
LobbyistsJENNIFER CAVE · mr MICHAEL ANTHONY SHUPP · MADHUMITHA THYAGARAJAN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act,FY2024 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026